StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)

Close on Nov 17, 2026Market cap $82.56BP/E –Yield –

Moderna operating margin

Operating margin is operating income as a percentage of revenue.

Moderna's operating margin for the twelve months ending Jun 30, 2026 was -149.0%. For fiscal 2025 it was -158.1%, against -121.9% the year before. The highest annual figure on record is 72.0% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-158.1%−36.2
FY2024Dec 31, 2024-121.9%−60.0
FY2023Dec 31, 2023-61.9%−110.8
FY2022Dec 31, 202248.9%−23.1
FY2021Dec 31, 202172.0%+167.0
FY2020Dec 31, 2020-95.0%+815.0
FY2019Dec 31, 2019-910.0%−604.0
FY2018Dec 31, 2018-306.0%−175.1
FY2017Dec 31, 2017-130.9%+75.6
FY2016Dec 31, 2016-206.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-562.1%+76.7
Q1 FY2026Mar 31, 2026-356.8%+615.4
Q4 FY2025Dec 31, 2025-126.4%+2.6
Q3 FY2025Sep 30, 2025-25.6%−21.8
Q2 FY2025Jun 30, 2025-638.7%−73.2
Q1 FY2025Mar 31, 2025-972.2%−214.1
Q4 FY2024Dec 31, 2024-129.0%−129.2
Q3 FY2024Sep 30, 2024-3.8%+106.1
Q2 FY2024Jun 30, 2024-565.6%−22.8
Q1 FY2024Mar 31, 2024-758.1%−738.4
Q4 FY2023Dec 31, 20230.2%−30.9
Q3 FY2023Sep 30, 2023-109.9%−144.5
Q2 FY2023Jun 30, 2023-542.7%−594.3
Q1 FY2023Mar 31, 2023-19.7%−89.3
Q4 FY2022Dec 31, 202231.1%−43.9
Q3 FY2022Sep 30, 202234.7%−36.9
Q2 FY2022Jun 30, 202251.5%−18.8
Q1 FY2022Mar 31, 202269.7%+4.3
Q4 FY2021Dec 31, 202175.0%+123.2
Q3 FY2021Sep 30, 202171.6%+221.3
Q2 FY2021Jun 30, 202170.3%+252.4
Q1 FY2021Mar 31, 202165.4%+1702.9
Q4 FY2020Dec 31, 2020-48.2%+880.7
Q3 FY2020Sep 30, 2020-149.7%+617.4
Q2 FY2020Jun 30, 2020-182.1%+916.4
Q1 FY2020Mar 31, 2020-1637.5%−753.6
Q4 FY2019Dec 31, 2019-928.9%−496.9
Q3 FY2019Sep 30, 2019-767.1%−561.6
Q2 FY2019Jun 30, 2019-1098.4%−762.2
Q1 FY2019Mar 31, 2019-883.9%−617.3
Q4 FY2018Dec 31, 2018-432.0%−386.5
Q3 FY2018Sep 30, 2018-205.5%−45.7
Q2 FY2018Jun 30, 2018-336.3%−107.2
Q1 FY2018Mar 31, 2018-266.5%−50.7
Q4 FY2017Dec 31, 2017-45.5%–
Q3 FY2017Sep 30, 2017-159.8%–
Q2 FY2017Jun 30, 2017-229.1%–
Q1 FY2017Mar 31, 2017-215.9%–

More Moderna figures

See a number that looks wrong?